We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$259M
AUM Growth
+$626K
Cap. Flow
-$11M
Cap. Flow %
-4.26%
Top 10 Hldgs %
27.16%
Holding
343
New
40
Increased
92
Reduced
61
Closed
71

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.71M
2
KMB icon
Kimberly-Clark
KMB
+$5.62M
3
RSG icon
Republic Services
RSG
+$5.6M
4
PG icon
Procter & Gamble
PG
+$4.06M
5
DRI icon
Darden Restaurants
DRI
+$3.95M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$4.87M
2
HPQ icon
HP
HPQ
+$4.75M
3
HUM icon
Humana
HUM
+$4.26M
4
MKL icon
Markel Group
MKL
+$4.11M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.1M

Sector Composition

Rank Sector Weight
1 Technology 26.53%
2 Consumer Staples 11.11%
3 Industrials 10.54%
4 Financials 9.14%
5 Healthcare 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
276
Amgen
AMGN
$222B
-259
Closed -$49K
ANDE icon
277
Andersons Inc
ANDE
$2.22B
-3,122
Closed -$101K
BLV icon
278
Vanguard Long-Term Bond ETF
BLV
$5.75B
-46
Closed -$4K
BMRN icon
279
BioMarin Pharmaceuticals
BMRN
$12.4B
-46,134
Closed -$4.1M
CF icon
280
CF Industries
CF
$17.3B
-9,306
Closed -$380K
CI icon
281
Cigna
CI
$74.6B
-10,936
Closed -$1.76M
CNC icon
282
Centene
CNC
$32.5B
-352
Closed -$19K
COP icon
283
ConocoPhillips
COP
$141B
-816
Closed -$54K
CVS icon
284
CVS Health
CVS
$122B
-56,369
Closed -$3.04M
DLB icon
285
Dolby
DLB
$5.79B
-2,067
Closed -$130K
ELV icon
286
Elevance Health
ELV
$85.5B
-16,965
Closed -$4.87M
EMB icon
287
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
-146
Closed -$16K
ENOR icon
288
iShares MSCI Norway ETF
ENOR
$96M
-7,914
Closed -$198K
EPD icon
289
Enterprise Products Partners
EPD
$81.7B
-981
Closed -$29K
EWM icon
290
iShares MSCI Malaysia ETF
EWM
$325M
-3,365
Closed -$101K
FFIV icon
291
F5
FFIV
$22.7B
-1,940
Closed -$304K
GES
292
DELISTED
Guess Inc
GES
-5,426
Closed -$106K
GSLC icon
293
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
-124
Closed -$7K
GWW icon
294
W.W. Grainger
GWW
$60.2B
-1,059
Closed -$319K
HPQ icon
295
HP
HPQ
$27.5B
-244,629
Closed -$4.75M
HRB icon
296
H&R Block
HRB
$5.86B
-11,676
Closed -$280K
HSIC icon
297
Henry Schein
HSIC
$9.82B
-4,624
Closed -$278K
HUM icon
298
Humana
HUM
$46.2B
-16,013
Closed -$4.26M
IFF icon
299
International Flavors & Fragrances
IFF
$21.9B
-2,398
Closed -$309K
INTU icon
300
Intuit
INTU
$89B
-109
Closed -$28K

Similar funds

Contravisory Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Contravisory Investment Management held 343 positions worth $259M, up 0.24% from $258M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Contravisory Investment Management withdrew a net $11M in Q2 2019, closing 71 positions and reducing 61 holdings. Its most notable exit was Elevance Health, an estimated $4.87M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Contravisory Investment Management opened a new position in AvalonBay Communities worth $3.9M.

  • Contravisory Investment Management's largest Q2 2019 buy was AvalonBay Communities: 19,217 shares worth $3.9M.
  • Contravisory Investment Management added most to Microsoft in Q2 2019, an estimated $5.71M increase.
  • Contravisory Investment Management's biggest Q2 2019 reduction was Universal Health Services, cutting an estimated $588K.
  • Contravisory Investment Management fully exited Elevance Health in Q2 2019, selling an estimated $4.87M.
  • Contravisory Investment Management's ten largest holdings make up 27% of its $259M portfolio in Q2 2019.
  • Contravisory Investment Management opened 40 new positions and closed 71 in Q2 2019.
  • Contravisory Investment Management's portfolio value rose 0.24% quarter-over-quarter to $259M.

Based on Contravisory Investment Management's 13F filing for Q2 2019, filed 9 Jul 2019.